{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:34:43Z","timestamp":1778902483979,"version":"3.51.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.contraception.2018.05.008","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T02:51:53Z","timestamp":1526439113000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Morbid obesity: potential effects of hormonal contraception"],"prefix":"10.1016","volume":"98","author":[{"given":"Frank Z.","family":"Stanczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne E.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt M.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2018.05.008_bb0005","author":"World Health Organization"},{"key":"10.1016\/j.contraception.2018.05.008_bb0010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajog.2003.09.058","article-title":"Obesity, obstetric complications and cesarean delivery rate\u2014a population-based screening study","volume":"190","author":"Weiss","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.maturitas.2009.09.006","article-title":"Predictors of chronic disease at midlife and beyond--the health risks of obesity","volume":"65","author":"Nejat","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2018.05.008_bb0020","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1001\/jama.2016.6458","article-title":"Trends in obesity among adults in the United States, 2005 to 2014","volume":"315","author":"Flegal","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2018.05.008_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/clpt.2011.104","article-title":"Implications of obesity for drug therapy: limitations and challenges","volume":"90","author":"Jain","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.contraception.2018.05.008_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40005-013-0073-4","article-title":"Obesity-related changes and their pharmacokinetic consequences","volume":"43","author":"Cho","year":"2013","journal-title":"J Pharm Investig"},{"key":"10.1016\/j.contraception.2018.05.008_bb0035","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2362.1998.00360.x","article-title":"Relationship between blood pressure, metabolic variables and blood flow in obese subjects with or without non-insulin-dependent diabetes mellitus","volume":"28","author":"Jansson","year":"1998","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.contraception.2018.05.008_bb0040","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1042\/cs0910679","article-title":"Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity","volume":"91","author":"Summers","year":"1996","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.contraception.2018.05.008_bb0045","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1517\/17425255.2011.570331","article-title":"The effects of obesity on drug pharmacokinetics in humans","volume":"7","author":"Morrish","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0050","first-page":"133","article-title":"Pharmacokinetics of ethynyloestradiol in humans","volume":"4","author":"Fotherby","year":"1982","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0055","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0022-4731(87)90197-X","article-title":"Estrogen receptors and androgen receptors in mammalian liver","volume":"27","author":"Eisenfeld","year":"1987","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2018.05.008_bb0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0065","series-title":"Clinical Gynecologic Endocrinology and Infertility","first-page":"691","year":"2005"},{"key":"10.1016\/j.contraception.2018.05.008_bb0070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmed.2007.12.003","article-title":"Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis","volume":"14","author":"Marra","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.contraception.2018.05.008_bb0075","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0080","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.contraception.2018.05.008_bb0085","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/0024-3205(90)90431-P","article-title":"Metabolism of 17 alpha-ethynylestradiol in humans","volume":"47","author":"Guengerich","year":"1990","journal-title":"Life Sci"},{"key":"10.1016\/j.contraception.2018.05.008_bb0090","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0002-9378(89)80010-9","article-title":"Pharmacology of contraceptive steroids: a brief review","volume":"160","author":"Goldzieher","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0039-128X(80)90001-X","article-title":"Chromatographic patterns of urinary ethynyl estrogen metabolites in various populations","volume":"36","author":"Williams","year":"1980","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2018.05.008_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2008.10.035","article-title":"Androgen metabolism in adipose tissue: recent advances","volume":"301","author":"Blouin","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0105","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.contraception.2010.01.016","article-title":"Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women","volume":"81","author":"Westhoff","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0110","series-title":"Goodman & Gilman's the Pharmacologic Basis of Therapeutics","year":"1996"},{"key":"10.1016\/j.contraception.2018.05.008_bb0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0010-7824(87)90005-9","article-title":"Presence of ethynyl-estradiol (EE-2) in blood and endometrium after interrupting steroidal contraception for three months","volume":"36","author":"Sojo-Aranda","year":"1987","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0010-7824(90)90093-B","article-title":"Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids","volume":"42","author":"Stanczyk","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2014.04.008","article-title":"Understanding androgen action in adipose tissue","volume":"143","author":"O'Reilly","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0022-4731(82)90629-X","article-title":"Distribution and percentages of non-protein bound contraceptive steroids in human serum","volume":"17","author":"Hammond","year":"1982","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2018.05.008_bb0135","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1210\/jcem-63-6-1257","article-title":"Sex steroid, gonadotropin, cortisol, and prolactin levels in healthy, massively obese women: correlation with abdominal fat cell size and effect of weight reduction","volume":"63","author":"Grenman","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2018.05.008_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.steroids.2015.03.016","article-title":"Steroid biosynthesis in adipose tissue","volume":"103","author":"Li","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2018.05.008_bb0145","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1517\/17425255.2010.482930","article-title":"Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state","volume":"6","author":"Feng","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11599410-000000000-00000","article-title":"Impact of obesity on drug metabolism and elimination in adults and children","volume":"51","author":"Brill","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.contraception.2018.05.008_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.21037\/atm.2017.03.107","article-title":"Morbidity and mortality associated with obesity","volume":"5","author":"Abdelaal","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.contraception.2018.05.008_bb0160","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jacc.2014.01.022","article-title":"Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox","volume":"63","author":"Lavie","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 4","key":"10.1016\/j.contraception.2018.05.008_bb0165","first-page":"S3","article-title":"The progression of cardiovascular risk to cardiovascular disease","volume":"8","author":"Rosin","year":"2007","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.contraception.2018.05.008_bb0170","first-page":"65","article-title":"Critical care of the morbidly obese patient","author":"Brusco","year":"2010","journal-title":"Curr Concepts Adult Crit Care"},{"key":"10.1016\/j.contraception.2018.05.008_bb0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13098-015-0040-5","article-title":"The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women","volume":"7","author":"Valderhaug","year":"2015","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.contraception.2018.05.008_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40248-016-0066-z","article-title":"Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function","volume":"11","author":"Mafort","year":"2016","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.contraception.2018.05.008_bb0185","series-title":"Morbid obesity: Peri-operative management","article-title":"Intensive care management of the critically ill obese patient","author":"Choi","year":"2010"},{"key":"10.1016\/j.contraception.2018.05.008_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40620-017-0377-y","article-title":"Obesity and kidney disease: hidden consequences of the epidemic","volume":"30","author":"Kovesdy","year":"2017","journal-title":"J Nephrol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0195","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1053\/j.ackd.2010.05.010","article-title":"Estimating the glomerular filtration rate in obese adult patients for drug dosing","volume":"17","author":"Pai","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"11 Suppl 1","key":"10.1016\/j.contraception.2018.05.008_bb0200","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1210\/jc.2008-1399","article-title":"Obesity-associated liver disease","volume":"93","author":"Marchesini","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2018.05.008_bb0205","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2018.05.008_bb0210","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","article-title":"Hepatic histology in obese patients undergoing bariatric surgery","volume":"45","author":"Machado","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0215","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MOH.0b013e3283634443","article-title":"Mechanisms of thrombosis in obesity","volume":"20","author":"Blokhin","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7243\/2054-9911-2-3","article-title":"Elevated body fat is a risk factor for venous thromboembolism and thrombotic complications","volume":"2","author":"Garc\u00eda-Raso","year":"2014","journal-title":"Epidemiol Rep"},{"key":"10.1016\/j.contraception.2018.05.008_bb0225","first-page":"14","article-title":"Effect of high fat-diet and obesity on gastrointestinal motility","volume":"1","author":"Mushref","year":"2013","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.contraception.2018.05.008_bb0230","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1381\/0960892041590854","article-title":"Manometric abnormalities and gastroesophageal reflux disease in the morbidly obese","volume":"14","author":"Hong","year":"2004","journal-title":"Obes Surg"},{"key":"10.1016\/j.contraception.2018.05.008_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001673","article-title":"Association between class III obesity (BMI of 40-59 kg\/m2) and mortality: a pooled analysis of 20 prospective studies","volume":"11","author":"Kitahara","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.contraception.2018.05.008_bb0240","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.fertnstert.2016.07.1094","article-title":"Hormonal contraception and obesity","volume":"106","author":"Simmons","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2018.05.008_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0250","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.contraception.2014.06.033","article-title":"Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial","volume":"90","author":"Edelman","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0255","article-title":"Hormonal contraceptives for contraception in overweight or obese women","volume":"8","author":"Lopez","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2018.05.008_bb0260","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.contraception.2016.08.001","article-title":"Effect of BMI and body weight on pregnancy rates with LNG as emergency contraception: analysis of four WHO HRP studies","volume":"95","author":"Festin","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0265","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.contraception.2016.03.006","article-title":"Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing","volume":"94","author":"Edelman","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0270","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.contraception.2016.05.002","article-title":"Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review","volume":"94","author":"Jatlaoui","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0275","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.contraception.2017.01.004","article-title":"Pharmacokinetics of levonorgestrel and ulipristal acetate emergency contraception in women with normal and obese body mass index","volume":"95","author":"Praditpan","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0280","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0002-9378(78)90288-0","article-title":"Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulator young women","volume":"130","author":"Edman","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0285","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/j.1550-8528.1994.tb00045.x","article-title":"A perspective on the hormonal abnormalities of obesity: are they cause or effect?","volume":"2","author":"Zumoff","year":"1994","journal-title":"Obes Res"},{"issue":"8 Suppl","key":"10.1016\/j.contraception.2018.05.008_bb0290","first-page":"3289s","article-title":"Relationship of obesity to blood estrogens","volume":"42","author":"Zumoff","year":"1982","journal-title":"Cancer Res"},{"key":"10.1016\/j.contraception.2018.05.008_bb0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.0954-6820.1987.tb05939.x","article-title":"Hormonal abnormalities in obesity","volume":"723","author":"Zumoff","year":"1987","journal-title":"Acta Med Scand Suppl"},{"key":"10.1016\/j.contraception.2018.05.008_bb0300","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.contraception.2006.04.005","article-title":"Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins","volume":"74","author":"White","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0305","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2007.01.027","article-title":"Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen","volume":"75","author":"Sitruk-Ware","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0310","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.contraception.2016.05.014","article-title":"Combined hormonal contraceptive use among obese women and risk of cardiovascular events: a systematic review","volume":"94","author":"Horton","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0315","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2018.05.008_bb0320","doi-asserted-by":"crossref","first-page":"66S","DOI":"10.1097\/01.AOG.0000514850.20849.1f","article-title":"Levonorgestrel intrauterine device complications among obese women in a multiracial population","author":"Saito-Tom","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0325","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.fertnstert.2014.03.004","article-title":"Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies","volume":"101","author":"Apter","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2018.05.008_bb0330","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2016.08.003","article-title":"Clarification of contraceptive drug pharmacokinetics in obesity","volume":"95","author":"Jusko","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.05.008_bb0335","first-page":"131","article-title":"Clinical utility of phentermine\/topiramate (Qsymia\u2122) combination for the treatment of obesity","volume":"6","author":"Shin","year":"2013","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.contraception.2018.05.008_bb0340","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","article-title":"Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study","volume":"366","author":"Yusuf","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2018.05.008_bb0345","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.amjcard.2017.12.038","article-title":"Relation of waist-hip ratio to long-term cardiovascular events in patients with coronary artery disease","volume":"121","author":"Medina-Inojosa","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0350","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","article-title":"Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study","volume":"388","author":"O'Donnell","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2018.05.008_bb0355","first-page":"1","article-title":"The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis","volume":"2","author":"Lu","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0360","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.contraception.2018.05.008_bb0365","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1007\/s11695-017-2629-2","article-title":"Health-related quality of life, anxiety, and depression in bariatric surgery candidates compared to patients from a psychosomatic inpatient hospital","volume":"27","author":"Osterhues","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/j.contraception.2018.05.008_bb0370","author":"Centers for Disease Control"},{"key":"10.1016\/j.contraception.2018.05.008_bb0375","series-title":"UK Medical Eligibility Criteria for Contraceptive Use (UKMEC 2005\/2006)","author":"Faculty of Sexual & Reproductive Healthcare","year":"2006"},{"key":"10.1016\/j.contraception.2018.05.008_bb0380","first-page":"1","article-title":"U.S. Selected Practice Recommendations for Contraceptive Use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm. Rep."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418301847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418301847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:11:12Z","timestamp":1778299872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782418301847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0010782418301847"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2018.05.008","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morbid obesity: potential effects of hormonal contraception","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2018.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}